Phosphodiesterase 3B's Role in Adipose Tissue and Metabolic Health

This study explores the role of a protein called Phosphodiesterase 3B (PDE3B), which is involved in how the body processes nutrients like sugars and fats. Researchers have discovered that some people with a specific genetic change affecting PDE3B might be less likely to develop diabetes and heart disease. The study aims to understand the role of PDE3B in fat tissue function and its impact on blood sugar and fat levels. By understanding these processes better, the study could lead to new strategies to prevent or manage diabetes and heart disease. Participants in the study will include both those with the genetic variant affecting PDE3B and those with the usual gene type. The study involves two visits. The first is a 4-hour screening where participants undergo a medical check-up, blood tests before and after consuming a sugary drink, and assessments of lifestyle factors like physical activity, sleep, and diet. For those eligible, a 24-hour visit includes an insulin infusion and collection of blood and fat tissue samples. The main focus is to measure lipolysis, which is how the body breaks down fats, using a special technique involving stable isotope tracers. This research could provide valuable insights into how PDE3B influences nutrient handling in the body and help develop preventive measures for related diseases.